Have a feature idea you'd love to see implemented?
Let us know!
NKGN NKGen Biotech Inc
Price (delayed)
$0.3375
Market cap
$11.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.08
Enterprise value
$39.72M
graf industrial corp is a blank check company. the company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
Highlights
NKGen Biotech's gross profit has surged by 100% YoY
NKGen Biotech's net income has shrunk by 196% YoY and by 10% QoQ
The revenue has dropped by 100% year-on-year
Key stats
What are the main financial stats of NKGN
Market
Valuations
Earnings
Shares outstanding
35.36M
Market cap
$11.93M
Enterprise value
$39.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$85.88M
EBITDA
-$84.45M
Free cash flow
-$21.54M
Per share
Balance sheet
Liquidity
EPS
-$5.08
Free cash flow per share
-$0.89
Book value per share
-$2.71
Revenue per share
$0
TBVPS
$0.64
Total assets
$15.65M
Total liabilities
$85.37M
Debt
$28.12M
Equity
-$69.72M
Working capital
-$50.16M
Debt to equity
-0.4
Current ratio
0.02
Quick ratio
0.01
Net debt/EBITDA
-0.33
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-479.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NKGN stock price
How has the NKGen Biotech stock price performed over time
Intraday
7.83%
1 week
21.8%
1 month
-25.2%
1 year
-87.82%
YTD
-87.73%
QTD
-10.71%
Financial performance
How have NKGen Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.41M
Net income
-$88.25M
Gross margin
N/A
Net margin
N/A
NKGen Biotech's net income has shrunk by 196% YoY and by 10% QoQ
NKGen Biotech's gross profit has surged by 100% YoY
The revenue has dropped by 100% year-on-year
NKGN's operating income is down by 22% year-on-year and by 2.8% since the previous quarter
Growth
What is NKGen Biotech's growth rate over time
Valuation
What is NKGen Biotech stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKGen Biotech's EPS has plunged by 58% YoY
The company's equity fell by 27% QoQ
The revenue has dropped by 100% year-on-year
Efficiency
How efficient is NKGen Biotech business performance
NKGen Biotech's ROA has decreased by 18% from the previous quarter
Dividends
What is NKGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NKGN.
Financial health
How did NKGen Biotech financials performed over time
The total assets is 82% smaller than the total liabilities
The company's total liabilities has surged by 155% YoY and by 20% QoQ
The company's quick ratio has shrunk by 83% YoY
The company's debt is 140% higher than its equity
NKGN's debt to equity has soared by 83% year-on-year
The company's equity fell by 27% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.